Unknown

Dataset Information

Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure.


ABSTRACT:

Background

The development of heart failure is accompanied by complex changes in cardiac electrophysiology and functional properties of cardiomyocytes and fibroblasts. Histone deacetylase (HDAC) inhibitors hold great promise for the pharmaceutical therapy of several malignant diseases. Here, we describe novel effects of the class I HDAC inhibitor Entinostat on electrical and structural remodeling in an in vivo model of pacing induced heart failure.

Methods

Rabbits were implanted a pacemaker system, subjected to rapid ventricular pacing and treated with Entinostat or placebo, respectively. Following stimulation, rabbit hearts were explanted and subsequently subjected to electrophysiological studies and further immunohistological analyses of left ventricles.

Results

In

SUBMITTER: Freundt JK 

PROVIDER: S-EPMC6404297 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature